14.99
price up icon2.25%   0.33
after-market Dopo l'orario di chiusura: 14.70 -0.29 -1.93%
loading
Precedente Chiudi:
$14.66
Aprire:
$14.72
Volume 24 ore:
1.75M
Relative Volume:
1.26
Capitalizzazione di mercato:
$1.46B
Reddito:
$221.08M
Utile/perdita netta:
$-2.92M
Rapporto P/E:
299.80
EPS:
0.05
Flusso di cassa netto:
$5.89M
1 W Prestazione:
+2.53%
1M Prestazione:
+33.13%
6M Prestazione:
+96.20%
1 anno Prestazione:
+1.83%
Intervallo 1D:
Value
$14.54
$15.13
Intervallo di 1 settimana:
Value
$14.21
$15.41
Portata 52W:
Value
$6.38
$16.66

Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile

Name
Nome
Avadel Pharmaceuticals Plc
Name
Telefono
636-449-1830
Name
Indirizzo
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN
Name
Dipendente
188
Name
Cinguettio
@AvadelPharma
Name
Prossima data di guadagno
2025-03-03
Name
Ultimi documenti SEC
Name
AVDL's Discussions on Twitter

Confronta AVDL con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
AVDL
Avadel Pharmaceuticals Plc
14.99 1.45B 221.08M -2.92M 5.89M 0.05
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
153.20 67.75B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.29 47.88B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.84 43.70B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.48 21.51B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
380.47 18.31B 2.99B 1.21B 1.13B 25.06

Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-18 Ripresa H.C. Wainwright Buy
2025-02-11 Iniziato Deutsche Bank Buy
2024-06-12 Iniziato Rodman & Renshaw Buy
2024-03-05 Reiterato H.C. Wainwright Buy
2024-03-05 Reiterato Needham Buy
2024-03-05 Reiterato Oppenheimer Outperform
2024-02-06 Iniziato UBS Buy
2022-11-30 Aggiornamento Jefferies Hold → Buy
2022-08-10 Downgrade Jefferies Buy → Hold
2022-07-28 Ripresa Craig Hallum Buy
2022-05-26 Downgrade Stifel Buy → Hold
2021-09-23 Iniziato Needham Buy
2020-07-31 Iniziato Oppenheimer Outperform
2020-07-21 Iniziato SVB Leerink Outperform
2020-06-30 Iniziato H.C. Wainwright Buy
2020-04-03 Iniziato Jefferies Buy
2020-03-12 Iniziato Stifel Buy
2020-02-26 Iniziato Piper Sandler Overweight
2020-01-30 Iniziato Craig Hallum Buy
2019-06-14 Aggiornamento Ladenburg Thalmann Neutral → Buy
2019-02-08 Downgrade Ladenburg Thalmann Buy → Neutral
Mostra tutto

Avadel Pharmaceuticals Plc Borsa (AVDL) Ultime notizie

pulisher
Sep 03, 2025

Avadel licenses once-at-bedtime oxybate therapy from XWPharma - Investing.com

Sep 03, 2025
pulisher
Sep 03, 2025

Avadel Pharmaceuticals and XWPharma Enter Exclusive License Agreement for Valiloxybate, a Novel Once-at-Bedtime Oxybate for Sleep Disorders - Quiver Quantitative

Sep 03, 2025
pulisher
Sep 03, 2025

Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd - The Manila Times

Sep 03, 2025
pulisher
Sep 03, 2025

Salt-Free Sleep Drug Deal: Avadel Pharma Expands Portfolio with $20M Valiloxybate License for Narcolepsy - Stock Titan

Sep 03, 2025
pulisher
Sep 03, 2025

Is Avadel Pharmaceuticals plc currently under institutional pressureJuly 2025 Recap & Reliable Breakout Stock Forecasts - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Wells Fargo Initiates Avadel Pharmaceuticals at Equalweight With $16 Price Target - MarketScreener

Sep 03, 2025
pulisher
Sep 03, 2025

Applying Elliott Wave Theory to Avadel Pharmaceuticals plc2025 Fundamental Recap & Weekly High Return Forecasts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is now a turning point for Avadel Pharmaceuticals plcMarket Activity Summary & Breakout Confirmation Trade Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Avadel Pharmaceuticals plc a candidate for recovery playEarnings Risk Summary & Smart Swing Trading Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is a relief rally coming for Avadel Pharmaceuticals plc holdersQuarterly Risk Review & Expert Curated Trade Setup Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will Avadel Pharmaceuticals plc benefit from macro trendsForecast Cut & Advanced Technical Analysis Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Avadel Pharmaceuticals plc stock chart pattern explained2025 Market Outlook & AI Forecast Swing Trade Picks - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Tick level data insight on Avadel Pharmaceuticals plc volatilityJuly 2025 Big Picture & Real-Time Chart Breakout Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can you recover from losses in Avadel Pharmaceuticals plcInflation Watch & Free Risk Controlled Daily Trade Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Sector ETF performance correlation with Avadel Pharmaceuticals plcWeekly Volume Report & Weekly High Conviction Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will Avadel Pharmaceuticals plc continue its uptrendQuarterly Risk Review & Daily Risk Controlled Trade Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Custom watchlist performance reports with Avadel Pharmaceuticals plcJuly 2025 Short Interest & Proven Capital Preservation Methods - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will Avadel Pharmaceuticals plc outperform the marketPortfolio Gains Summary & Accurate Trade Setup Notifications - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Smart tools for monitoring Avadel Pharmaceuticals plc’s price action2025 Support & Resistance & Long-Term Growth Stock Strategies - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What earnings revisions data tells us about Avadel Pharmaceuticals plcJuly 2025 Momentum & Fast Gain Swing Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Predicting Avadel Pharmaceuticals plc trend using moving averagesInsider Selling & Technical Entry and Exit Tips - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Published on: 2025-09-02 22:45:08 - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is now the right time to enter Avadel Pharmaceuticals plcMarket Volume Summary & Real-Time Market Sentiment Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Pullback Watch: Is Avadel Pharmaceuticals plc exposed to political riskMarket Activity Summary & High Return Trade Guides - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Can Avadel Pharmaceuticals plc benefit from deglobalizationQuarterly Performance Summary & Community Driven Trade Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Avadel Pharmaceuticals plc (AVDL)’s LUMRYZ™ Sales Surge 64% in Breakout Quarter - MSN

Sep 02, 2025
pulisher
Sep 02, 2025

How to use a screener to detect Avadel Pharmaceuticals plc breakoutsWeekly Trade Review & Accurate Intraday Trade Tips - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

Is Avadel Pharmaceuticals plc building a consolidation base2025 Fundamental Recap & Consistent Profit Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

How to read the order book for Avadel Pharmaceuticals plcBond Market & Daily Technical Forecast Reports - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Risk adjusted return profile for Avadel Pharmaceuticals plc analyzedJuly 2025 Selloffs & Real-Time Volume Analysis - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Trend analysis for Avadel Pharmaceuticals plc this weekPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Avadel Pharmaceuticals plc Inches Above Key Support — Safe to Hold getLinesFromResByArray error: size == 0 - kangso.co.kr

Aug 31, 2025
pulisher
Aug 30, 2025

Avadel Pharmaceuticals plc stock momentum explainedWeekly Gains Report & AI Powered Market Trend Analysis - Newser

Aug 30, 2025

Avadel Pharmaceuticals Plc Azioni (AVDL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Avadel Pharmaceuticals Plc Azioni (AVDL) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Thornton Peter J.
Director
Jan 13 '25
Buy
8.04
10,000
80,450
104,055
Ende Eric J
Director
Jan 13 '25
Buy
7.84
30,000
235,218
208,900
MCHUGH THOMAS S
Chief Financial Officer
Dec 13 '24
Buy
10.44
2,300
24,019
87,800
MCHUGH THOMAS S
Chief Financial Officer
Dec 11 '24
Buy
10.49
5,000
52,432
85,500
Divis Gregory J
Chief Executive Officer
Dec 06 '24
Buy
9.98
9,598
95,759
9,598
Divis Gregory J
Chief Executive Officer
Dec 09 '24
Buy
9.82
402
3,948
10,000
Glass Geoffrey Michael
Director
Dec 10 '24
Buy
9.84
20,279
199,641
75,904
Palczuk Linda
Director
Dec 06 '24
Buy
10.19
3,000
30,568
66,400
$28.92
price down icon 3.60%
$17.47
price up icon 0.69%
drug_manufacturers_specialty_generic RDY
$14.15
price down icon 0.28%
$10.33
price down icon 2.09%
$140.40
price up icon 3.15%
$380.47
price down icon 2.80%
Capitalizzazione:     |  Volume (24 ore):